CD4 and B-cell non-Hodgkin lymphoma: Both, iatrogenic immune suppression with tacrolimus (FK506) that mainly affects CD4+ T cell activation and expansion after EBV infection of humanized mice, and CD4+ T cell depletion by HIV co-infection leads to elevated viral loads and increased EBV associated B cell lymphoma formation (71, 72).